News

Press ReleaseKing's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumours
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Cell and Gene Therapy Catapult invests in Lir Therapeutics to accelerate development of its AI-driven AAV design platformCell and Gene Therapy Catapult invests in Lir Therapeutics to accelerate development of its AI-driven AAV design platformR&D project spotlight: Advancing automated manufacturing in cell and gene therapiesR&D project spotlight: Advancing automated manufacturing in cell and gene therapiesRegulatory Round-up - April 2026Regulatory Round-up - April 2026Stratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeuticsStratosvir secures support from Cell and Gene Therapy Catapult to advance innovative anticancer therapeuticsRegulatory Round-up - March 2026Regulatory Round-up - March 2026New survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductionsNew survey shows UK cell and gene therapy industry expects workforce to return to growth, following a challenging period of headcount reductionsRegulatory Round-up - February 2026Regulatory Round-up - February 2026Cross sector collaboration is vital to bringing more life-changing therapies to people with rare diseasesCross sector collaboration is vital to bringing more life-changing therapies to people with rare diseasesCGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovationsCGT Catapult establishes Technology Advisory Board to identify opportunities for the advanced therapies sector to deploy and benefit from innovationsRegulatory Round-up - January 2026Regulatory Round-up - January 2026R&D project spotlight: Leveraging advanced analytics for detailed process characterisation in iPSC natural killer cell therapy generationR&D project spotlight: Leveraging advanced analytics for detailed process characterisation in iPSC natural killer cell therapy generationNew data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining highNew data shows continued growth in advanced therapy clinical trials in the UK for 2025, with the number of early-stage trials remaining high